ResearcherUniversity of ZurichNo recent work listed
Kuno Lehmann
Matched on ORCID iD 0000-0002-6177-9543; OpenAlex author ID A5090081694. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 30
2023: 2 papers
Papers 2
- FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analy… Last author DOI 10.1245/s10434-023-13353-2↗
- ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection Cuts the Deal. Last author DOI 10.1245/s10434-023-13484-6↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Russell F. Palm · 2 shared papers, 2023 · strength 0.38
- Paper ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection … DOI 10.1245/s10434-023-13484-6↗
- Paper FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-… DOI 10.1245/s10434-023-13353-2↗
- Dilmurodjon Eshmuminov · 2 shared papers, 2023 · strength 0.38
- Paper ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection … DOI 10.1245/s10434-023-13484-6↗
- Paper FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-… DOI 10.1245/s10434-023-13353-2↗
- Matthew H. G. Katz · 1 shared paper, 2023 · strength 0.12
- Raëf Abdallah · 1 shared paper, 2023 · strength 0.12
- Jin‐Young Jang · 1 shared paper, 2023 · strength 0.12
- Giuseppe Malleo · 1 shared paper, 2023 · strength 0.12
- Gregory C. Wilson · 1 shared paper, 2023 · strength 0.12
- Ryan K. Schmocker · 1 shared paper, 2023 · strength 0.12
- Jin Peng He · 1 shared paper, 2023 · strength 0.12
- Sarah Maloney · 1 shared paper, 2023 · strength 0.12
- John Bart Rose · 1 shared paper, 2023 · strength 0.12
- Yoo Jin Choi · 1 shared paper, 2023 · strength 0.12
- Hongbeom Kim · 1 shared paper, 2023 · strength 0.12
- Klaus Sahora · 1 shared paper, 2023 · strength 0.12
- Thomas Malinka · 1 shared paper, 2023 · strength 0.12
- Syed Ameen Ahmad · 1 shared paper, 2023 · strength 0.12
- Laura Maggino · 1 shared paper, 2023 · strength 0.12
- Pierre‐Alain Clavien · 1 shared paper, 2023 · strength 0.12
- Jeong Youp Park · 1 shared paper, 2023 · strength 0.12
- Lea Timmermann · 1 shared paper, 2023 · strength 0.12
- Víctor López‐López · 1 shared paper, 2023 · strength 0.12
- Laura R. Prakash · 1 shared paper, 2023 · strength 0.12
- Elena B. Rangelova · 1 shared paper, 2023 · strength 0.12
- Scott W. Helton · 1 shared paper, 2023 · strength 0.12
- Sarah E. Hoffe · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.